Jump to Content
Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo
Society for Endocrinology logo
Sign in Create account
Home Browse
Current issue All issues Accepted manuscripts Special Collections Special issues
Submit now How to submit Author guidelines Reasons to publish Peer review Research data Ethical policy Open-access policy Post-publication changes Publication charges Author resource centre
Subscribe
Contact the journal About Endocrine-Related Cancer Scope Editorial board Societies For libraries Abstracting and indexing Vacancy closed: Editor-in-Chief
Alerts Journals
Advanced Search Help
Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo
Society for Endocrinology logo
Sign in Create account
Home Browse
Current issue All issues Accepted manuscripts Special Collections Special issues
Submit now How to submit Author guidelines Reasons to publish Peer review Research data Ethical policy Open-access policy Post-publication changes Publication charges Author resource centre
Subscribe
Contact the journal About Endocrine-Related Cancer Scope Editorial board Societies For libraries Abstracting and indexing Vacancy closed: Editor-in-Chief
Alerts Journals
Advanced Search Help

Volume 29 (2022): Issue 6 (Jun 2022)

in Endocrine-Related Cancer
Online ISSN:
1479-6821
Print ISSN:
1351-0088

Articles are added to the current issue and list of accepted manuscripts on an ongoing basis, reflecting the journal's continuous publication.

Sign up using the button to receive email notifications of the latest research.

Sign up for journal news
Review
Translating the immune microenvironment of thyroid cancer into clinical practice
Research
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures
Effects of dabrafenib and erlotinib combination treatment on anaplastic thyroid carcinoma
C/EBPβ mediates anti-proliferative effects of 1,25(OH)2D on differentiated thyroid carcinoma cells
Everolimus with or without bevacizumab in advanced pNET: CALGB 80701 (Alliance)
A suppressor of dioxygenase inhibition in a yeast model of SDH deficiency
Oophorectomy improves pituitary activin inhibitory function preventing lactotroph hyperplasia development
Preclinical evaluation of targeted therapies in Sdhb-mutated tumors
  • Save
  • Collapse
  • Expand
  • Top
Print ISSN:
1351-0088
Online ISSN:
1479-6821

Online ISSN: 1479-6821
Print ISSN: 1351-0088

Follow the journal on Twitter

Author Information

Author Guidelines

Open Access Policy

Permissions

Librarian Information

General Information

Products and Prices

Read and Publish Deal

General Information

Contact the journal

Advertising

Help

Bioscientifica logo

Strengthening biomedical communities
to advance science and health

 

Accessibility

Privacy and Cookies

Terms and Conditions

 

About Bioscientifica

All Bioscientifica Journals

Publishing Alliances

 

CONTACT US

Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK

Bioscientifica Ltd | Registered in England no 3190519

© 2024 Bioscientifica Ltd
Powered by PubFactory
  • [18.97.14.89]
  • 18.97.14.89
Close
Edit

Character limit 500/500

@!

Character limit 500/500